The main role and efficacy of voriconazole injection is used for the treatment of serious infectious diseases caused by various fungi.
The main component of voriconazole injection is voriconazole, which is a broad-spectrum triazole antifungal drug, mainly by inhibiting the biosynthesis of ergosterol in the fungal cell membrane, which plays an antifungal role. Clinically, it is mainly used for the treatment of invasive aspergillosis, severe invasive Candida infections resistant to fluconazole, and severe infections caused by Actinomyces spp. and Fusarium spp.
Common adverse reactions after the application of voriconazole injection include visual disturbances, drug rash, liver function abnormalities, fever, nausea, vomiting, diarrhea, headache, sepsis, peripheral edema or abdominal pain. If the above symptoms occur after the use of the drug patients should immediately stop the drug, and promptly go to the hospital, consult the attending physician whether it is necessary to adjust the dose of the drug or the use of other drugs to replace the treatment.
Voriconazole injection is prohibited for those who are allergic to the drug components; at the same time, the drug is prohibited from combining with CYP3A4 substrates, common drugs such as terfenadine, astemizole, cisapride, pimozide or quinidine. It is prohibited for use in pregnant patients and pediatric patients under 12 years of age.
Voriconazole injection needs to be standardized under the guidance of a professional doctor, it is recommended that patients with the need for medication to go to a regular hospital in a timely manner, under the guidance of a doctor to clarify whether there are indications for the use of medication, and after a full understanding of the indications of the drug, contraindications, and adverse reactions, and other matters to standardize the application of the drug.